← Leaderboards
Michael Cohenwolkowiez
Duke University
$419,415
Attributed
$419,415
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $291K · FY2015–17$500K$375K$250K$125K$0
'15
'16
'17
Funding mix
By agency
NIH$419,415 · 1
By mechanism
N01$419,415 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Michael Barry Kastan$65,974,699
- Herbert Kim Lyerly$48,598,090
- John H Sampson$43,413,436
- Walter J Koch$36,219,689
- Nelson J. Chao$27,968,804
Others in their field
Top investigators on “Phase I Clinical Trials”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$674,722,986
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$549,289,302
- Barton F Haynes · Duke University$532,133,792
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$407,280,377
Research focus
Phase I Clinical TrialsInfectious Disease TreatmentInvestigationNovel TherapeuticsOperationClinical Trials UnitImmunoregulationClinical Infrastructure